RECRUITING
I'm interested ...!!
MCG Discovery Study in Emergency Departments
This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is whether interpretable data can be reliably collected as part of an ED workflow.
Conditions:
🦠 ACS - Acute Coronary Syndrome 🦠 NSTEMI - Non-ST Segment Elevation MI
🗓️ Study Start (Actual) 30 October 2023
🗓️ Primary Completion (Estimated) July 2024
✅ Study Completion (Estimated) August 2024
👥 Enrollment (Estimated) 100
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 New York, New York, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Presents to ED with symptoms of Acute Coronary Syndrome (ACS)
    • * Can provide written consent

    Exclusion Criteria:

    • * Presents to ED with ST-Elevation Myocardial Infarction (STEMI)
    • * Presents to ED with Atrial Fibrillation
    • * Clear non-ischemic cause for symptoms (i.e. trauma)
    • * Active thoracic metal implants
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 12 October 2023
  • First Submitted that Met QC Criteria 18 October 2023
  • First Posted 23 October 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 25 June 2024
  • Last Update Posted 27 June 2024
  • Last Verified June 2024
I'm interested ...!!